IDXX
2025Q4BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS2.94
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move5.0%
IV front—
P/C full—
P/C front—
Features as of2026-01-30
Run-up
Close—
Ret 5d-3.4%
Ret 10d-5.9%
Ret 20d-0.9%
Ret 30d-3.3%
Actual EPS
3.08Beat
Estimated EPS2.94
Actual revenue
1.1B
Surprise %+4.8%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction-2.6%
Implied vs actual
Implied 5.0%Actual 2.0%
Gap reaction-2.0%
Day result-4.6%
Next-day upNo
Realized / IV0.40×
Post tape
Post 5d+0.0%
Post 10d-2.1%
Post volume1.0M
Vol ×10d2.07×
Vol ×20d2.14×
Post range5.5%